Target intelligence / Profile preview

Helicobacter pylori cell wall peptidoglycan (H. pylori PGN)

Target
H. pylori PGN
Molecular classification
Bacterial cell wall component, Polysaccharide-peptide polymer, Other
01

Overview

Helicobacter pylori cell wall peptidoglycan is a vital structural heteropolymer that provides mechanical strength and maintains the osmotic stability of the bacterium within the harsh gastric environment. It is composed of glycan strands of alternating N-acetylglucosamine and N-acetylmuramic acid residues, which are cross-linked by short peptide chains (Viala et al., 2004, Science, DOI: 10.1126/science.1103471). This structure is essential for the survival and spiral morphology of H. pylori, which is necessary for its motility through the gastric mucus. In a clinical context, the peptidoglycan is a primary target for beta-lactam antibiotics like amoxicillin, which disrupt the cross-linking process, resulting in bacterial death (StatPearls, 2023, 'Amoxicillin'). Beyond its structural role, H. pylori peptidoglycan acts as a potent pathogen-associated molecular pattern (PAMP). Fragments of the peptidoglycan are delivered into host gastric epithelial cells via the Cag type IV secretion system, where they are sensed by the intracellular pattern recognition receptor NOD1 (Chamaillard et al., 2003, Nature Immunology, DOI: 10.1038/ni937). This recognition triggers the NF-kappaB signaling pathway, leading to the production of pro-inflammatory cytokines and contributing to the chronic inflammation associated with gastric ulcers and cancer.

Other names
MureinH. pylori peptidoglycanBacterial cell wall polymerPeptidoglycan layer
02

Mechanism of action

Inhibition of peptidoglycan biosynthesis by binding to penicillin-binding proteins (PBPs), leading to cell wall weakening and osmotic lysis; enzymatic hydrolysis of beta-1,4-glycosidic bonds by lysozyme; activation of host NOD1 receptors by peptidoglycan fragments.

03

Biological functions

Structural integrityOsmotic protectionCell shape maintenanceCell divisionImmune response induction
04

Disease associations

InfectionGastritisPeptic ulcer diseaseGastric adenocarcinomaMALT lymphoma
05

Safety considerations

Antibiotic resistance developmentDisruption of gut microbiota (dysbiosis)Inflammatory response due to bacterial lysis products
06

Interacting drugs

Amoxicillin

3 more in the full profile.

07

Biomarkers

Peptidoglycan-derived muramic acid levelsNOD1 activation markersSoluble peptidoglycan fragments

Beyond the preview

Go deeper on Helicobacter pylori cell wall peptidoglycan (H. pylori PGN).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Helicobacter pylori cell wall peptidoglycan (H. pylori PGN).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call